{"id":45612,"date":"2022-06-28T22:01:25","date_gmt":"2022-06-28T20:01:25","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/invacare-corporation-to-participate-in-the-22nd-annual-cjs-securities-new-ideas-summer-conference\/"},"modified":"2022-06-28T22:01:25","modified_gmt":"2022-06-28T20:01:25","slug":"invacare-corporation-to-participate-in-the-22nd-annual-cjs-securities-new-ideas-summer-conference","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/invacare-corporation-to-participate-in-the-22nd-annual-cjs-securities-new-ideas-summer-conference\/","title":{"rendered":"Invacare Corporation to Participate in the 22nd Annual CJS Securities New Ideas Summer Conference"},"content":{"rendered":"
\n

ELYRIA, Ohio–(BUSINESS WIRE)–Matt Monaghan, chairman, president and chief executive officer of Invacare Corporation (NYSE: IVC); Kathy Leneghan, senior vice president and chief financial officer; and Lois Lee, director, treasury, investor relations and corporate communications, will participate in the 22nd<\/sup> Annual New Ideas Summer Conference on Tuesday, July 12, 2022.\n<\/p>\n

<\/a><\/p>\n

\nThe company\u2019s management team will be available for 1×1 meetings with interested investors.\n<\/p>\n

\nAbout Invacare Corporation<\/b>\n<\/p>\n

\nInvacare Corporation is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings. At its core, the company designs, manufactures and distributes medical devices that help people to move, breathe, rest and perform essential hygiene. The company provides clinically complex medical device solutions for congenital (e.g., cerebral palsy, muscular dystrophy, spina bifida), acquired (e.g., stroke, spinal cord injury, traumatic brain injury, post-acute recovery, pressure ulcers) and degenerative (e.g., ALS, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly, bariatric) ailments. The company’s products are important parts of care for people with a wide range of challenges, from those who are active and involved in work or school each day and may need additional mobility or respiratory support, to those who are cared for in residential care settings, at home and in rehabilitation centers. The company sells its products principally to home medical equipment providers with retail and e-commerce channels, residential care operators, distributors and government health services in North America, Europe and Asia\/Pacific. For more information about the company and its products, visit Invacare’s website at www.invacare.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nLois Lee
\n
loislee@invacare.com<\/a>
440-329-6435\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

ELYRIA, Ohio–(BUSINESS WIRE)–Matt Monaghan, chairman, president and chief executive officer of Invacare Corporation (NYSE: IVC); Kathy Leneghan, senior vice president and chief financial officer; and Lois Lee, director, treasury, investor relations and corporate communications, will participate in the 22nd Annual New Ideas Summer Conference on Tuesday, July 12, 2022. The company\u2019s management team will be … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-45612","6":"format-standard","7":"category-industry"},"yoast_head":"\nInvacare Corporation to Participate in the 22nd Annual CJS Securities New Ideas Summer Conference - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/invacare-corporation-to-participate-in-the-22nd-annual-cjs-securities-new-ideas-summer-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Invacare Corporation to Participate in the 22nd Annual CJS Securities New Ideas Summer Conference - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"ELYRIA, Ohio–(BUSINESS WIRE)–Matt Monaghan, chairman, president and chief executive officer of Invacare Corporation (NYSE: IVC); Kathy Leneghan, senior vice president and chief financial officer; and Lois Lee, director, treasury, investor relations and corporate communications, will participate in the 22nd Annual New Ideas Summer Conference on Tuesday, July 12, 2022. The company\u2019s management team will be ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/invacare-corporation-to-participate-in-the-22nd-annual-cjs-securities-new-ideas-summer-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-28T20:01:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220628005834\/en\/226269\/21\/Invacare_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/invacare-corporation-to-participate-in-the-22nd-annual-cjs-securities-new-ideas-summer-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/invacare-corporation-to-participate-in-the-22nd-annual-cjs-securities-new-ideas-summer-conference\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Invacare Corporation to Participate in the 22nd Annual CJS Securities New Ideas Summer Conference\",\"datePublished\":\"2022-06-28T20:01:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/invacare-corporation-to-participate-in-the-22nd-annual-cjs-securities-new-ideas-summer-conference\\\/\"},\"wordCount\":278,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/invacare-corporation-to-participate-in-the-22nd-annual-cjs-securities-new-ideas-summer-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220628005834\\\/en\\\/226269\\\/21\\\/Invacare_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/invacare-corporation-to-participate-in-the-22nd-annual-cjs-securities-new-ideas-summer-conference\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/invacare-corporation-to-participate-in-the-22nd-annual-cjs-securities-new-ideas-summer-conference\\\/\",\"name\":\"Invacare Corporation to Participate in the 22nd Annual CJS Securities New Ideas Summer Conference - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/invacare-corporation-to-participate-in-the-22nd-annual-cjs-securities-new-ideas-summer-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/invacare-corporation-to-participate-in-the-22nd-annual-cjs-securities-new-ideas-summer-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220628005834\\\/en\\\/226269\\\/21\\\/Invacare_Logo.jpg\",\"datePublished\":\"2022-06-28T20:01:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/invacare-corporation-to-participate-in-the-22nd-annual-cjs-securities-new-ideas-summer-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/invacare-corporation-to-participate-in-the-22nd-annual-cjs-securities-new-ideas-summer-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/invacare-corporation-to-participate-in-the-22nd-annual-cjs-securities-new-ideas-summer-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220628005834\\\/en\\\/226269\\\/21\\\/Invacare_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220628005834\\\/en\\\/226269\\\/21\\\/Invacare_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/invacare-corporation-to-participate-in-the-22nd-annual-cjs-securities-new-ideas-summer-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Invacare Corporation to Participate in the 22nd Annual CJS Securities New Ideas Summer Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Invacare Corporation to Participate in the 22nd Annual CJS Securities New Ideas Summer Conference - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/invacare-corporation-to-participate-in-the-22nd-annual-cjs-securities-new-ideas-summer-conference\/","og_locale":"en_US","og_type":"article","og_title":"Invacare Corporation to Participate in the 22nd Annual CJS Securities New Ideas Summer Conference - Pharma Trend","og_description":"ELYRIA, Ohio–(BUSINESS WIRE)–Matt Monaghan, chairman, president and chief executive officer of Invacare Corporation (NYSE: IVC); Kathy Leneghan, senior vice president and chief financial officer; and Lois Lee, director, treasury, investor relations and corporate communications, will participate in the 22nd Annual New Ideas Summer Conference on Tuesday, July 12, 2022. The company\u2019s management team will be ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/invacare-corporation-to-participate-in-the-22nd-annual-cjs-securities-new-ideas-summer-conference\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-28T20:01:25+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220628005834\/en\/226269\/21\/Invacare_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/invacare-corporation-to-participate-in-the-22nd-annual-cjs-securities-new-ideas-summer-conference\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/invacare-corporation-to-participate-in-the-22nd-annual-cjs-securities-new-ideas-summer-conference\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Invacare Corporation to Participate in the 22nd Annual CJS Securities New Ideas Summer Conference","datePublished":"2022-06-28T20:01:25+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/invacare-corporation-to-participate-in-the-22nd-annual-cjs-securities-new-ideas-summer-conference\/"},"wordCount":278,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/invacare-corporation-to-participate-in-the-22nd-annual-cjs-securities-new-ideas-summer-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220628005834\/en\/226269\/21\/Invacare_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/invacare-corporation-to-participate-in-the-22nd-annual-cjs-securities-new-ideas-summer-conference\/","url":"https:\/\/pharma-trend.com\/en\/invacare-corporation-to-participate-in-the-22nd-annual-cjs-securities-new-ideas-summer-conference\/","name":"Invacare Corporation to Participate in the 22nd Annual CJS Securities New Ideas Summer Conference - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/invacare-corporation-to-participate-in-the-22nd-annual-cjs-securities-new-ideas-summer-conference\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/invacare-corporation-to-participate-in-the-22nd-annual-cjs-securities-new-ideas-summer-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220628005834\/en\/226269\/21\/Invacare_Logo.jpg","datePublished":"2022-06-28T20:01:25+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/invacare-corporation-to-participate-in-the-22nd-annual-cjs-securities-new-ideas-summer-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/invacare-corporation-to-participate-in-the-22nd-annual-cjs-securities-new-ideas-summer-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/invacare-corporation-to-participate-in-the-22nd-annual-cjs-securities-new-ideas-summer-conference\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220628005834\/en\/226269\/21\/Invacare_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220628005834\/en\/226269\/21\/Invacare_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/invacare-corporation-to-participate-in-the-22nd-annual-cjs-securities-new-ideas-summer-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Invacare Corporation to Participate in the 22nd Annual CJS Securities New Ideas Summer Conference"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45612","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=45612"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45612\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=45612"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=45612"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=45612"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}